Advances in mRNA and other vaccines against MERS-CoV.

Advances in mRNA and other vaccines against MERS-CoV.
复制标题

DOI:
10.1016/j.trsl.2021.11.007
复制
发表时间:
2022-04
期刊:
Translational research : the journal of laboratory and clinical medicine
影响因子:
--
通讯作者:
Du L
Du L
中科院分区:
其他
文献类型:
--
作者:
Tai W;Zhang X;Yang Y;Zhu J;Du L

文献摘要

参考文献

被引文献

相似文献

中东呼吸综合征冠状病毒(MERS-CoV)是一种高致病性的人类冠状病毒(CoV)。MERS-CoV与严重急性呼吸综合征冠状病毒1型(SARS-CoV-1)和SARS-CoV-2属于同一种β-CoV属,具有显著更高的致死率,但人与人之间的传播性有限。MERS-CoV引起零星爆发,但尚未批准用于人类的疫苗,因此需要继续努力开发针对这种重要CoV的有效疫苗。与SARS-CoV-1和SARS-CoV-2相似,MERS-CoV含有4种结构蛋白,其中表面刺突蛋白(S)已被用作大多数目前开发的MERS-CoV疫苗的核心组分。在这里,我们说明了MERS-CoV S蛋白作为关键疫苗靶标的重要性,并提供了目前开发的MERS-CoV疫苗的最新信息,包括基于DNA、蛋白质、病毒样颗粒或纳米颗粒以及病毒载体的疫苗。此外,我们描述了设计MERS-CoV mRNA疫苗的方法,并探讨了天然存在的假核苷在设计有效的MERS-CoV mRNA疫苗中的作用和重要性。这篇综述也为设计和评估针对其他病毒病原体的mRNA疫苗提供了有用的见解。
Middle East respiratory syndrome coronavirus (MERS-CoV) is a highly pathogenic human coronavirus (CoV). Belonging to the same beta-CoV genus as severe acute respiratory syndrome coronavirus-1 (SARS-CoV-1) and SARS-CoV-2, MERS-CoV has a significantly higher fatality rate with limited human-to-human transmissibility. MERS-CoV causes sporadic outbreaks, but no vaccines have yet been approved for use in humans, thus calling for continued efforts to develop effective vaccines against this important CoV. Similar to SARS-CoV-1 and SARS-CoV-2, MERS-CoV contains 4 structural proteins, among which the surface spike (S) protein has been used as a core component in the majority of currently developed MERS-CoV vaccines. Here, we illustrate the importance of the MERS-CoV S protein as a key vaccine target and provide an update on the currently developed MERS-CoV vaccines, including those based on DNAs, proteins, virus-like particles or nanoparticles, and viral vectors. Additionally, we describe approaches for designing MERS-CoV mRNA vaccines and explore the role and importance of naturally occurring pseudo-nucleosides in the design of effective MERS-CoV mRNA vaccines. This review also provides useful insights into designing and evaluating mRNA vaccines against other viral pathogens.
通过探索MERS-COV蛋白质组的基于多表位亚基疫苗的合理设计:反疫苗学和分子对接方法。
DOI: 10.1371/journal.pone.0245072
发表时间: 2021
期刊: PloS one
影响因子: 3.7
作者:
Ashfaq UA;Saleem S;Masoud MS;Ahmad M;Nahid N;Bhatti R;Almatroudi A;Khurshid M
通讯作者: Khurshid M
DOI: 10.15585/mmwr.mm7038e2
发表时间: 2021-09-24
期刊: MMWR. Morbidity and mortality weekly report
影响因子: --
作者:
Dooling K;Gargano JW;Moulia D;Wallace M;Rosenblum HG;Blain AE;Hadler SC;Plumb ID;Moline H;Gerstein J;Collins JP;Godfrey M;Campos-Outcalt D;Morgan RL;Brooks O;Talbot HK;Lee GM;Daley MF;Oliver SE
通讯作者: Oliver SE
DOI: 10.1038/s41541-021-00303-w
发表时间: 2021-03-19
期刊: NPJ vaccines
影响因子: 9.2
作者:
Cho H;Jang Y;Park KH;Choi H;Nowakowska A;Lee HJ;Kim M;Kang MH;Kim JH;Shin HY;Oh YK;Kim YB
通讯作者: Kim YB
DOI: 10.1128/jvi.01048-13
发表时间: 2013-09-01
影响因子: 5.4
作者:
Du, Lanying;Zhao, Guangyu;Jiang, Shibo
通讯作者: Jiang, Shibo
DOI: 10.1080/14728222.2017.1271415
发表时间: 2017-02
影响因子: 5.8
作者:
Du L;Yang Y;Zhou Y;Lu L;Li F;Jiang S
通讯作者: Jiang S